{"id": "1356591221284757507", "creation": 1612271526.0, "user_id": "879161563", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 15, "reply_count": 0, "like_count": 23, "quote_count": 1}}, "text": "Interim analysis of Russian #COVID19 #vaccine phase 3 trial of 20,000 participants shows two-dose regimen has efficacy of 91.6% against symptomatic #COVID19. No serious adverse events deemed to be associated with vaccination https://t.co/5fGc0QkIX0", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#COVID19"]}